Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 1 Open-label Study of TRX518 Monotherapy and TRX518 in Combination With Gemcitabine, Pembrolizumab, or Nivolumab

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02628574
Recruitment Status : Active, not recruiting
First Posted : December 11, 2015
Last Update Posted : September 25, 2019
Sponsor:
Information provided by (Responsible Party):
Leap Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 2020
Estimated Study Completion Date : September 2020